Pathogenic autoantibodies in lupus nephritis

M. Waldman, Michael P. Madaio

Research output: Contribution to journalReview article

110 Citations (Scopus)

Abstract

Lupus nephritis is a major complication of systemic lupus erythematosus (SLE) and is associated with a high rate of morbidity and mortality. While many different immunologic and nonimmunologic factors contribute to disease expression in lupus nephritis, a large body of evidence suggests that the production of anti-DNA antibodies and the formation of glomerular immune deposits are important initial events in the pathogenesis of the disease. This review will summarize our current understanding of the differences between pathogenic and nonpathogenic autoantibodies, the mechanisms by which these autoantibodies induce renal injury and the effector mechanisms which are subsequently activated by the deposited autoantibodies that ultimately lead to the expression of the different lupus lesions.

Original languageEnglish (US)
Pages (from-to)19-24
Number of pages6
JournalLupus
Volume14
Issue number1
DOIs
StatePublished - Feb 21 2005

Fingerprint

Lupus Nephritis
Autoantibodies
Antinuclear Antibodies
Immunologic Factors
Systemic Lupus Erythematosus
Antibody Formation
Morbidity
Kidney
Mortality
Wounds and Injuries

Keywords

  • Autoantibodies
  • Lupus
  • Nephritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Pathogenic autoantibodies in lupus nephritis. / Waldman, M.; Madaio, Michael P.

In: Lupus, Vol. 14, No. 1, 21.02.2005, p. 19-24.

Research output: Contribution to journalReview article

Waldman, M & Madaio, MP 2005, 'Pathogenic autoantibodies in lupus nephritis', Lupus, vol. 14, no. 1, pp. 19-24. https://doi.org/10.1191/0961203305lu2054oa
Waldman, M. ; Madaio, Michael P. / Pathogenic autoantibodies in lupus nephritis. In: Lupus. 2005 ; Vol. 14, No. 1. pp. 19-24.
@article{cd628abfd08248bbba5ab6a7b0b1eb1e,
title = "Pathogenic autoantibodies in lupus nephritis",
abstract = "Lupus nephritis is a major complication of systemic lupus erythematosus (SLE) and is associated with a high rate of morbidity and mortality. While many different immunologic and nonimmunologic factors contribute to disease expression in lupus nephritis, a large body of evidence suggests that the production of anti-DNA antibodies and the formation of glomerular immune deposits are important initial events in the pathogenesis of the disease. This review will summarize our current understanding of the differences between pathogenic and nonpathogenic autoantibodies, the mechanisms by which these autoantibodies induce renal injury and the effector mechanisms which are subsequently activated by the deposited autoantibodies that ultimately lead to the expression of the different lupus lesions.",
keywords = "Autoantibodies, Lupus, Nephritis",
author = "M. Waldman and Madaio, {Michael P.}",
year = "2005",
month = "2",
day = "21",
doi = "10.1191/0961203305lu2054oa",
language = "English (US)",
volume = "14",
pages = "19--24",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Pathogenic autoantibodies in lupus nephritis

AU - Waldman, M.

AU - Madaio, Michael P.

PY - 2005/2/21

Y1 - 2005/2/21

N2 - Lupus nephritis is a major complication of systemic lupus erythematosus (SLE) and is associated with a high rate of morbidity and mortality. While many different immunologic and nonimmunologic factors contribute to disease expression in lupus nephritis, a large body of evidence suggests that the production of anti-DNA antibodies and the formation of glomerular immune deposits are important initial events in the pathogenesis of the disease. This review will summarize our current understanding of the differences between pathogenic and nonpathogenic autoantibodies, the mechanisms by which these autoantibodies induce renal injury and the effector mechanisms which are subsequently activated by the deposited autoantibodies that ultimately lead to the expression of the different lupus lesions.

AB - Lupus nephritis is a major complication of systemic lupus erythematosus (SLE) and is associated with a high rate of morbidity and mortality. While many different immunologic and nonimmunologic factors contribute to disease expression in lupus nephritis, a large body of evidence suggests that the production of anti-DNA antibodies and the formation of glomerular immune deposits are important initial events in the pathogenesis of the disease. This review will summarize our current understanding of the differences between pathogenic and nonpathogenic autoantibodies, the mechanisms by which these autoantibodies induce renal injury and the effector mechanisms which are subsequently activated by the deposited autoantibodies that ultimately lead to the expression of the different lupus lesions.

KW - Autoantibodies

KW - Lupus

KW - Nephritis

UR - http://www.scopus.com/inward/record.url?scp=13444291211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13444291211&partnerID=8YFLogxK

U2 - 10.1191/0961203305lu2054oa

DO - 10.1191/0961203305lu2054oa

M3 - Review article

C2 - 15732283

AN - SCOPUS:13444291211

VL - 14

SP - 19

EP - 24

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 1

ER -